Johnson & Johnson (NYSE:JNJ) was among Jim Cramer’s stock calls on Mad Money, as he highlighted the AI opportunities in neoclouds.
Cramer was bullish on the stock and expects positive developments for the company, as he stated: You’re going to see some massive moves in real time for no reason whatsoever
Why do we care about this? Because these rotations create dislocations that seem to come out of nowhere, and sometimes those dislocations can give you incredible opportunities to [buy, buy, buy] high-quality companies at a discount that shouldn’t even exist, and it wouldn’t if weren’t for the rotation. Today, we got a bunch of them.
I’ve been recommending Johnson & Johnson ever since they mostly got past the overhang from all those talc lawsuits. No, the asbestos litigation hasn’t gone away, but J&J’s now fighting each case individually so there are really no major rulings that can impact the stock that much. Johnson & Johnson reports on the 15th of July.